Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study.

NCT03677336 is registered in ClinicalTrials.gov with CRG UZ Brussel as lead sponsor.

NCT NCT03677336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03677336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study.
Lead sponsor
CRG UZ Brussel
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2019
Completion date
August 24, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dydrogesterone, genital diseases, female, genital diseases, male, hormones, hormones, hormone substitutes, and hormone antagonists, infertility, infertility, female, physiological effects of drugs, progesterone, progestins